Last month’s British HIV Association (BHIVA) Conference in Birmingham heard that the programme of opt-out testing for the blood-borne viruses HIV, hepatitis B and hepatitis C in hospital emergency departments has now involved 4.3 million tests for the three viruses: 1.9 million for HIV, 1 million for hepatitis B and 1.4 million for hepatitis C.
This is a nearly fourfold increase on the numbers presented a year ago from the first year’s data, which started in April 2022. The conference heard that the programme is particularly uncovering a large number of people with previously undiagnosed hepatitis B.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences
-
EurekAlert!: Between 2.4 and 4.1 million people estimated to be living with chronic hepatitis B infection in Europe
-
The Rockefeller University: A new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.